<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="brief-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biochem Biophys Res Commun</journal-id>
      <journal-title-group>
        <journal-title>Biochemical and Biophysical Research Communications</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0006-291X</issn>
      <issn pub-type="epub">1090-2104</issn>
      <publisher>
        <publisher-name>Academic Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3105224</article-id>
      <article-id pub-id-type="pmid">21513697</article-id>
      <article-id pub-id-type="publisher-id">YBBRC26569</article-id>
      <article-id pub-id-type="doi">10.1016/j.bbrc.2011.04.024</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Reduced endothelial dependent vasodilation in vessels from TLR4<sup>−/−</sup> mice is associated with increased superoxide generation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Harrington</surname>
            <given-names>Louise S.</given-names>
          </name>
          <email>l.harrington@imperial.ac.uk</email>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lundberg</surname>
            <given-names>Martina H.</given-names>
          </name>
          <email>martina.lundberg08@imperial.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Waight</surname>
            <given-names>Michael</given-names>
          </name>
          <email>michael.waight06@imperial.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rozario</surname>
            <given-names>Adrian</given-names>
          </name>
          <email>adrian.rozario05@imperial.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mitchell</surname>
            <given-names>Jane A.</given-names>
          </name>
          <email>j.a.mitchell@imperial.ac.uk</email>
        </contrib>
      </contrib-group>
      <aff>Cardiothoracic Pharmacology, NHLI, Imperial College, Dovehouse Street, London SW3 6LY, UK</aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Corresponding author. Fax: +44 0207 823 3392. <email>l.harrington@imperial.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>20</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <day>20</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <volume>408</volume>
      <issue>4</issue>
      <fpage>511</fpage>
      <lpage>515</lpage>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>4</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2011 Elsevier Inc.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="graphical">
        <title>Highlights</title>
        <p>► The absence of TLR4 is associated with reduced endothelial cell function in mesenteric arteries. ► TLR4<sup>−/−</sup> mouse arteries have reduced acetylcholine responses. ► TLR4<sup>−/−</sup> have increased superoxide levels when stimulated with acetylcholine. ► An increase in superoxide generation reduces the activity of endothelial derived nitric oxide.</p>
      </abstract>
      <abstract>
        <p>Toll like receptor (TLR)4 is a pattern recognition receptor expressed in endothelial and other cells, responsible for the sensing of endotoxin and host derived ligands. Our group has shown previously that the absence of TLR4 is associated with reduced endothelial dependent vasodilator responses and left heart hypertrophy in animal models. However, the mechanism behind reduced endothelial cell function in TLR4<sup>−/−</sup> mice is not known.</p>
        <p>We have used <italic>en face</italic> confocal imaging of mesenteric arteries from mice deficient in the TLR4 receptor stained with dihydroethidium (DHE) to measure superoxide production. Using the isometric wire myograph, mesenteric artery vasodilator responses to acetylcholine and MnCl<sub>2</sub> (a superoxide dismutase mimetic) were measured. Mesenteric arteries from TLR4<sup>−/−</sup> mice had a reduced endothelial dependent relaxant response and increased superoxide levels when stimulated with acetylcholine. Increased levels of superoxide, as detected by DHE staining, were seen in vessels from TLR4<sup>−/−</sup> mice, which were reduced to control levels in the presence of MnCl<sub>2</sub>.</p>
        <p>Our observations suggest that loss of TLR4 increases superoxide generation which reduces the biological activity of endothelial derived nitric oxide and thereby explains the endothelial dysfunction and associated cardiovascular phenotype in TLR4<sup>−/−</sup> mice. These data implicate a novel cardio-protective role for TLR4 in vascular homeostasis.</p>
      </abstract>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>TLR, Toll like receptor</kwd>
        <kwd>DHE, dihydroethidium</kwd>
        <kwd>DAPI, 4′,6-diamidino-2-phenylinodole</kwd>
        <kwd>Nox, NADPH oxidase</kwd>
        <kwd>U46619, 9,11-dideoxy-11α,9α-epoxymethanoprostaglandin F<sub>2α</sub></kwd>
        <kwd>PSS, physiological saline solution</kwd>
        <kwd>Ach, acetylcholine</kwd>
        <kwd>SNP, sodium nitroprusside</kwd>
        <kwd>SOD, superoxide dismutase</kwd>
      </kwd-group>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Toll like receptor 4</kwd>
        <kwd>Basal nitric oxide</kwd>
        <kwd>Superoxide</kwd>
        <kwd>Vasodilation</kwd>
        <kwd>Artery</kwd>
        <kwd>Dihydroethidium</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s0005">
      <label>1</label>
      <title>Introduction</title>
      <p>Endothelial cells mediate vasodilation by the release of vasoactive hormones including nitric oxide and prostacyclin <xref rid="b0005" ref-type="bibr">[1]</xref>. In most blood vessels, including those used in this study, nitric oxide is the dominant endothelial vasodilator hormone <xref rid="b0010" ref-type="bibr">[2]</xref>. The biological activity of nitric oxide is critically influenced by levels of superoxide anions and the quenching of superoxide radicals results in enhanced vasodilation in bioassay systems when endothelial cells are stimulated <xref rid="b0015" ref-type="bibr">[3]</xref>. We have recently shown that endothelial dependent vasodilation is significantly reduced in vessels from mice lacking the pattern recognition receptor, Toll like receptor (TLR)4 <xref rid="b0020" ref-type="bibr">[4]</xref>. Others have shown that TLR4<sup>−/−</sup> mice express increased levels of superoxide in isolated lung endothelial cells which leads to emphysema as the mice age <xref rid="b0025" ref-type="bibr">[5]</xref>. In the current study we have tested the hypothesis that blood vessels from TLR4<sup>−/−</sup> mice have increased superoxide levels and assessed how this may affect endothelial function in blood vessels from these mice <xref rid="b0030" ref-type="bibr">[6]</xref>.</p>
    </sec>
    <sec sec-type="materials|methods" id="s0010">
      <label>2</label>
      <title>Materials and methods</title>
      <p>Female homozygous TLR4<sup>−/−</sup> mice on a C57 Black 6 background <xref rid="b0035" ref-type="bibr">[7]</xref> were provided by Sandra Sacré, Michael Goddard and Claudia Monaco (Kennedy Institute, London, UK). Age matched inbred wild type C57 Black 6 mice were obtained from Charles River (UK) and Harlan (UK). The mice were maintained and killed humanely in accordance with the EC Directive 86/609/EEC for animal experiments.</p>
      <p>Genotype was confirmed by PCR of DNA extracted from ear clips using Qiagen spin columns. PCR amplification was carried out using GE Healthcare PuRe PCR beads and the following primers: forward primer: cgt gta aac cag cca ggt ttt gaa ggc, reverse primer: tgt tgc cct tca gtc aca gag act ctg, and neomycin resistance gene primer: atc gcc ttc tat cgc ctt ctt gac gag. The reaction was cycled 35 times with 94 °C (for 15 s) denaturing, 60 °C (for 15 s) annealing and 72 °C (for 1 min) elongation temperatures.</p>
      <p>For isometric wire myography, vessel segments from wild type mice aged 10–16 weeks (12.9 ± 0.7 weeks) and TLR4<sup>−/−</sup> mice aged 11–16 weeks (13.0 ± 0.7 weeks) were used. Mice were killed by cervical dislocation and mesenteric arteries removed and prepared as described previously <xref rid="b0020" ref-type="bibr">[4]</xref>. Arteries were dissected free of fat and connective tissues, and the vessel segments placed in Mulvany wire myographs <xref rid="b0040" ref-type="bibr">[8]</xref> to measure contraction and relaxation responses. Throughout the experiment, tissues were immersed in physiological salt solution (PSS) 1.18 × 10<sup>−1</sup> mol/L NaCl, 4.7 × 10<sup>−3</sup> mol/L KCl, 1.17 × 10<sup>−3</sup> mol/L MgSO<sub>4</sub>, 2.5 × 10<sup>−3</sup> mol/L CaCl<sub>2</sub>, 1.0 × 10<sup>−3</sup> mol/L KH<sub>2</sub>PO<sub>4</sub>, 2.7 × 10<sup>−5</sup> mol/L EDTA, and 5.5 × 10<sup>−3</sup> mol/L glucose, at 36 °C, bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub>. The tension of the vessel was normalised to a tension equivalent to that generated at 90% of the diameter of the vessel at 100 mmHg. Changes in arterial tone were recorded via a PowerLab/800 recording unit (ADI instruments Pty Ltd., Australia), and analysed using Chart 6.0 acquisition system (ADI instruments).</p>
      <p>Arteries were exposed to two challenges of high potassium solution (KPSS; 1.24 × 10<sup>−1</sup> mol/L KCl, 1.17 × 10<sup>−3</sup> mol/L MgSO<sub>4</sub>, 2.5 × 10<sup>−3</sup> mol/L CaCl<sub>2</sub>, 1.0 × 10<sup>−3</sup> mol/L KH<sub>2</sub>PO<sub>4</sub>, 2.7 × 10<sup>−5</sup> mol/L EDTA, and 5.5 × 10<sup>−3</sup> mol/L glucose) followed by a washout period of 10 min. Concentration response curves to 9,11-dideoxy-11α,9α-epoxymethanoprostaglandin F<sub>2α</sub> (U46619; 10<sup>−9</sup>–3 × 10<sup>−7</sup> mol/L) were performed on each of the tissues. Dilatory response curves were recorded in arteries pre-contracted with an EC<sub>80</sub> concentration of U46619, and vasodilator responses to either acetylcholine (10<sup>−8</sup>–10<sup>−4</sup> mol/L) or MnCl<sub>2</sub> (10<sup>−8</sup>–3 × 10<sup>−4</sup> mol/L) were assessed.</p>
      <p>To image and quantify superoxide levels, wild type mice aged 9–11 weeks (mean 10.3 ± 0.2 weeks) and TLR4<sup>−/−</sup> mice aged 8–11 weeks (mean 9.8 ± 0.8 weeks) were used. Some arteries were exposed to the superoxide dismutase mimetic MnCl<sub>2</sub> (3 × 10<sup>−4</sup> mol/L) for 20 min prior to contracting the mesenteric arteries with EC<sub>80</sub> 9,11-dideoxy-11α,9α-epoxymethanoprostaglandin F<sub>2α</sub> (U46619). Arteries were left contracted for 10 min before the addition of dihydroethidium (DHE; 10<sup>−5</sup> mol/L), and a further 20 min before the addition of acetylcholine at increasing concentrations <xref rid="b0020" ref-type="bibr">[4]</xref>. DHE binds with superoxide to form 2-hydroxyethidium which can be imaged using confocal microscopy. At the end of these experiments tissues were fixed with 2% paraformaldehyde for 15 min. 4′,6-Diamidino-2-phenylinodole (DAPI; 7 × 10<sup>−6</sup> mol/L) was added for 5 min to visualise the nuclei. Arteries were mounted for confocal microscopy using hard-set vectashield medium, and images captured the following day using a Leica SP5 inverted microscope with LAS AF (2.0.2) software.</p>
      <p>Detection wavelength settings were 406–458 nm for DAPI (blue), and 575–700 nm for DHE (red) imaging. The gain and offset for each channel were determined in pilot studies, using a wild type Ach control artery to indicate maximum staining (set just below the saturation point). Following optimisation, all microscope settings were rigorously adhered to.</p>
      <p>Images through the <italic>Z</italic> plane of the whole mesenteric artery were achieved by locating the endothelial layer by morphology of the DAPI stained nuclei (rectangular, running perpendicular to the smooth muscle cells’ nuclei), and an image of the red DHE stained endothelial cells was taken. The focus was then changed to the smooth muscle cells above the endothelial cells indicated by the blue DAPI stained nuclei (elongated nuclei wrapping around the artery), and an image then taken of the red DHE staining. Due to differences in shape and size of each artery, the total pixel count was taken from within a rectangle of 168 μm × 183 μm moved within each image to exclude non-artery image. From each tissue, three sets of images (endothelial cells and the overlying smooth muscle cells) along the length of the artery were taken from each individual mouse.</p>
    </sec>
    <sec id="s0015">
      <label>3</label>
      <title>Results</title>
      <p>Each mouse genotype was confirmed to being a homozygous wild type or TLR4<sup>−/−</sup> by PCR. As we have shown previously <xref rid="b0020" ref-type="bibr">[4]</xref>, vessels from TLR4<sup>−/−</sup> mice had reduced endothelial dependent vasodilator response when stimulated with acetylcholine (<xref rid="f0005" ref-type="fig">Fig. 1</xref>A). Endothelium independent vasodilation induced by sodium nitroprusside (SNP) was unaffected by the deletion of the TLR4 gene (<xref rid="f0005" ref-type="fig">Fig. 1</xref>B). Vasodilation induced by the cell permeable superoxide dismutase mimetic, MnCl<sub>2</sub> <xref rid="b0045" ref-type="bibr">[9]</xref>, was similar in tissues from wild type and TLR4<sup>−/−</sup> mice (<xref rid="f0005" ref-type="fig">Fig. 1</xref>C). Addition of authentic superoxide dismutase (SOD), which does not enter cells readily, did not induce vasodilation in arteries from either wild type or TLR4<sup>−/−</sup> mice (<xref rid="f0005" ref-type="fig">Fig. 1</xref>D). Contractile responses to U46619 (<xref rid="f0010" ref-type="fig">Fig. 2</xref>A) and high [K<sup>+</sup>] (<xref rid="f0010" ref-type="fig">Fig. 2</xref>B) were modestly reduced in arteries from TLR4<sup>−/−</sup> mice compared with those from wild type controls.</p>
      <p>In parallel experiments superoxide levels in the endothelial cell (<xref rid="f0015" ref-type="fig">Fig. 3</xref>) and smooth muscle cell (<xref rid="f0020" ref-type="fig">Fig. 4</xref>) layers of mesenteric arteries were visualised and quantified in vessels from wild type and TLR4<sup>−/−</sup> mice. In vessels from wild type mice, superoxide levels were relatively low and not significantly inhibited by MnCl<sub>2</sub>. By contrast levels of superoxide were greatly increased in both endothelial cell and smooth muscle cell layers in arteries from TLR4<sup>−/−</sup> mice and reduced to control levels in the presence of MnCl<sub>2</sub> (<xref rid="f0015 f0020" ref-type="fig">Figs. 3 and 4</xref>).</p>
    </sec>
    <sec id="s0020">
      <label>4</label>
      <title>Discussion</title>
      <p>The ability of endothelial cells to release nitric oxide is an essential part of normal vascular homeostasis. Nitric oxide from the endothelium limits smooth cell proliferation, vasoconstriction and platelet reactivity by activating soluble guanylate cyclase leading to increased cGMP <xref rid="b0005" ref-type="bibr">[1]</xref>. Nitric oxide is very unstable with a half life of few seconds in aqueous solution <xref rid="b0015" ref-type="bibr">[3]</xref>. However, the biological half life of nitric oxide is greatly increased when superoxide anions are removed using dismutase enzymes or molecules <xref rid="b0015" ref-type="bibr">[3]</xref>. Consequently, where superoxide anions are elevated the biological activity of nitric oxide is greatly reduced <xref rid="b0050" ref-type="bibr">[10]</xref>.</p>
      <p>In previous studies from our group we have shown that nitric oxide mediated endothelial dependent vasodilator responses in murine vessels are greatly reduced in mice lacking TLR4 receptors <xref rid="b0020" ref-type="bibr">[4]</xref>. Others have shown that lung microvascular endothelial cells from TLR4<sup>−/−</sup> mice have increased expression of the respiration, and superoxide forming enzyme NADPH oxidase (Nox)3 <xref rid="b0025" ref-type="bibr">[5]</xref>. If the same phenomenon occurs in endothelial cells lining arteries, increased superoxide generation could explain the reduced endothelial-dependent vasodilator effect <xref rid="b0050" ref-type="bibr">[10]</xref>.</p>
      <p>We show using confocal imaging that vessels from TLR4<sup>−/−</sup> mice have greatly increased levels of superoxide in both endothelial cell and smooth muscle cell layers. DHE binds superoxide to form 2-hydroxyethidium, or with hydrogen peroxide to form ethidium <xref rid="b0055" ref-type="bibr">[11]</xref>. Our observations were validated and found to be specific for superoxide, since the superoxide dismutase mimetic MnCl<sub>2</sub> greatly reduces fluorescence intensity. Moreover, endothelial dependent vasodilation induced by MnCl<sub>2</sub> <xref rid="b0045" ref-type="bibr">[9]</xref>, unlike that induced by acetylcholine, was not limited in vessels from TLR4<sup>−/−</sup> mice. In this study, as in others <xref rid="b0060" ref-type="bibr">[12]</xref> authentic SOD did not induce meaningful dilator responses, this is likely due to the fact that the molecule is large and does not access cells and tissues easily. Acetylcholine activates the endothelium, increasing intracellular calcium which stimulates nitric oxide synthase to release nitric oxide <xref rid="b0005" ref-type="bibr">[1]</xref>. Activation of the endothelium by acetylcholine would also activate Nox enzymes and increase superoxide production. By contrast MnCl<sub>2</sub> induces endothelium-dependent vasodilation, without activating the endothelium, by removing superoxide and thereby enhancing the activity of ‘basally released’ nitric oxide. Whilst not conclusive, our observations showing differential effects of acetylcholine and MnCl<sub>2</sub> in vessels from TLR4<sup>−/−</sup> arteries are, therefore, consistent with our conclusions that increased superoxide generation in blood vessels accounts for dysfunction in endothelium-dependent vasodilation seen in vessels from TLR4<sup>−/−</sup> mice. Interestingly we found that vessels from TLR4<sup>−/−</sup> mice had modestly, but significantly, reduced contractile responses to U46619 or depolarising concentrations of K<sup>+</sup>. This could be a result of overall vascular dysfunction associated with increased superoxide production in the tissue. Indeed we observed increased superoxide levels in both endothelial cell and smooth muscle cell layers of the arteries.</p>
      <p>These findings highlight a homeostatic role for TLR4 in cardiovascular function and explain why vessels from TLR4<sup>−/−</sup> mice have compromised endothelial responses at the level of nitric oxide. Activation of TLR4 is generally considered to lead to pro-inflammatory effects in blood vessels and is linked to the development of septic shock <xref rid="b0065" ref-type="bibr">[13]</xref> and atherosclerosis <xref rid="b0070" ref-type="bibr">[14]</xref>. The human TLR4 polymorphisms Asp299Gly and Thr399Ile impair receptor function, and have been linked to a strong increase in acute coronary syndrome <xref rid="b0075" ref-type="bibr">[15]</xref>. Yet in different reports, the Asp299Gly polymorphism was associated with a reduced risk of atherosclerosis <xref rid="b0080" ref-type="bibr">[16]</xref>, while another found a significant reduction in acute coronary events associated with Asp299Gly <xref rid="b0085" ref-type="bibr">[17]</xref> compared to controls. These contrasting observations could be explained by the inevitable balance between the loss of TLR4 function in immune versus non-immune vascular cells. Loss of TLR4 on immune cells will lead to immune suppression and increased susceptibility to infection but on the other hand protection of non-immune host tissue from inflammation is associated with TLR4 activation. However, our data clearly illustrate a novel role for TLR4 in limiting superoxide generation and offering cardio-protection. We do not yet know if this is a direct effect of TLR4 or secondary to changes in the levels of infection/inflammation.</p>
    </sec>
    <sec id="s0025">
      <title>Sources of funding</title>
      <p>This work was funded by the Wellcome Trust.</p>
    </sec>
    <sec id="s0030">
      <title>Conflict of interest disclosure</title>
      <p>None.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="b0005">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitchell</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Harrington</surname>
              <given-names>L.S.</given-names>
            </name>
          </person-group>
          <article-title>Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium</article-title>
          <source>Exp. Physiol.</source>
          <volume>93</volume>
          <year>2008</year>
          <fpage>141</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">17965142</pub-id>
        </element-citation>
      </ref>
      <ref id="b0010">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrington</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Carrier</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Gallagher</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Gilroy</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Garland</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Elucidation of the temporal relationship between endothelial-derived NO and EDHF in mesenteric vessels</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <volume>293</volume>
          <year>2007</year>
          <fpage>H1682</fpage>
          <lpage>H1688</lpage>
          <pub-id pub-id-type="pmid">17557917</pub-id>
        </element-citation>
      </ref>
      <ref id="b0015">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gryglewski</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Moncada</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor</article-title>
          <source>Nature</source>
          <volume>320</volume>
          <year>1986</year>
          <fpage>454</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="pmid">3007998</pub-id>
        </element-citation>
      </ref>
      <ref id="b0020">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrington</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Belcher</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Carrier</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Homeostatic role of Toll-like receptor 4 in the endothelium and heart</article-title>
          <source>J. Cardiovasc. Pharmacol. Ther.</source>
          <volume>12</volume>
          <year>2007</year>
          <fpage>322</fpage>
          <lpage>326</lpage>
          <pub-id pub-id-type="pmid">18172227</pub-id>
        </element-citation>
      </ref>
      <ref id="b0025">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Shan</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Cohn</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>P.J.</given-names>
            </name>
          </person-group>
          <article-title>Toll-like receptor 4 deficiency causes pulmonary emphysema</article-title>
          <source>J. Clin. Invest.</source>
          <volume>116</volume>
          <year>2006</year>
          <fpage>3050</fpage>
          <lpage>3059</lpage>
          <pub-id pub-id-type="pmid">17053835</pub-id>
        </element-citation>
      </ref>
      <ref id="b0030">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitchell</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Ryffel</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Quesniaux</surname>
              <given-names>V.F.</given-names>
            </name>
            <name>
              <surname>Cartwright</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Paul-Clark</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Role of pattern-recognition receptors in cardiovascular health and disease</article-title>
          <source>Biochem. Soc. Trans.</source>
          <volume>35</volume>
          <year>2007</year>
          <fpage>1449</fpage>
          <lpage>1452</lpage>
          <pub-id pub-id-type="pmid">18031243</pub-id>
        </element-citation>
      </ref>
      <ref id="b0035">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoshino</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Kawai</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sanjo</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Akira</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product</article-title>
          <source>J. Immunol.</source>
          <volume>162</volume>
          <year>1999</year>
          <fpage>3749</fpage>
          <lpage>3752</lpage>
          <pub-id pub-id-type="pmid">10201887</pub-id>
        </element-citation>
      </ref>
      <ref id="b0040">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mulvany</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Halpern</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats</article-title>
          <source>Circ. Res.</source>
          <volume>41</volume>
          <year>1977</year>
          <fpage>19</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="pmid">862138</pub-id>
        </element-citation>
      </ref>
      <ref id="b0045">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MacKenzie</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Filippini</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Effects of superoxide dismutase mimetics on the activity of nitric oxide in rat aorta</article-title>
          <source>Br. J. Pharmacol.</source>
          <volume>127</volume>
          <year>1999</year>
          <fpage>1159</fpage>
          <lpage>1164</lpage>
          <pub-id pub-id-type="pmid">10455262</pub-id>
        </element-citation>
      </ref>
      <ref id="b0050">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kaley</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Koller</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Superoxide released to high intra-arteriolar pressure reduces nitric oxide-mediated shear stress- and agonist-induced dilations</article-title>
          <source>Circ. Res.</source>
          <volume>83</volume>
          <year>1998</year>
          <fpage>960</fpage>
          <lpage>965</lpage>
          <pub-id pub-id-type="pmid">9797346</pub-id>
        </element-citation>
      </ref>
      <ref id="b0055">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laurindo</surname>
              <given-names>F.R.</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>C.X.</given-names>
            </name>
          </person-group>
          <article-title>Assessment of superoxide production and NADPH oxidase activity by HPLC analysis of dihydroethidium oxidation products</article-title>
          <source>Methods Enzymol.</source>
          <volume>441</volume>
          <year>2008</year>
          <fpage>237</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="pmid">18554538</pub-id>
        </element-citation>
      </ref>
      <ref id="b0060">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MacKenzie</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Loss of endothelium-derived nitric oxide in rabbit aorta by oxidant stress: restoration by superoxide dismutase mimetics</article-title>
          <source>Br. J. Pharmacol.</source>
          <volume>124</volume>
          <year>1998</year>
          <fpage>719</fpage>
          <lpage>728</lpage>
          <pub-id pub-id-type="pmid">9690864</pub-id>
        </element-citation>
      </ref>
      <ref id="b0065">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cartwright</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>McMaster</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Sorrentino</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Paul-Clark</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sriskandan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ryffel</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Quesniaux</surname>
              <given-names>V.F.</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>T.W.</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Elucidation of Toll-like receptor and adapter protein signaling in vascular dysfunction induced by gram-positive <italic>Staphylococcus aureus</italic> or gram-negative <italic>Escherichia coli</italic></article-title>
          <source>Shock</source>
          <volume>27</volume>
          <year>2007</year>
          <fpage>40</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="pmid">17172979</pub-id>
        </element-citation>
      </ref>
      <ref id="b0070">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Michelsen</surname>
              <given-names>K.S.</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>P.K.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Yano</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Doherty</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Akira</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Rajavashisth</surname>
              <given-names>T.B.</given-names>
            </name>
            <name>
              <surname>Arditi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>101</volume>
          <year>2004</year>
          <fpage>10679</fpage>
          <lpage>10684</lpage>
          <pub-id pub-id-type="pmid">15249654</pub-id>
        </element-citation>
      </ref>
      <ref id="b0075">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O’Halloran</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Stanton</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>O’Brien</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>D.C.</given-names>
            </name>
          </person-group>
          <article-title>The impact on coronary artery disease of common polymorphisms known to modulate responses to pathogens</article-title>
          <source>Ann. Hum. Genet.</source>
          <volume>70</volume>
          <year>2006</year>
          <fpage>934</fpage>
          <lpage>945</lpage>
          <pub-id pub-id-type="pmid">17044867</pub-id>
        </element-citation>
      </ref>
      <ref id="b0080">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kiechl</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lorenz</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Reindl</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wiedermann</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Oberhollenzer</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bonora</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Willeit</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>Toll-like receptor 4 polymorphisms and atherogenesis</article-title>
          <source>N. Engl. J. Med.</source>
          <volume>347</volume>
          <year>2002</year>
          <fpage>185</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="pmid">12124407</pub-id>
        </element-citation>
      </ref>
      <ref id="b0085">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ameziane</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Beillat</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Verpillat</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Chollet-Martin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Aumont</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Seknadji</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Lamotte</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lebret</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ollivier</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>de Prost</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events</article-title>
          <source>Arterioscler. Thromb. Vasc. Biol.</source>
          <volume>23</volume>
          <year>2003</year>
          <fpage>e61</fpage>
          <lpage>e64</lpage>
          <pub-id pub-id-type="pmid">14563652</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack>
      <title>Acknowledgment</title>
      <p>We thank Mike Goddard of the Kennedy Institute (London, UK) for providing us with TLR4<sup>−/−</sup> and wild type control mice.</p>
    </ack>
  </back>
  <floats-group>
    <fig id="f0005">
      <label>Fig. 1</label>
      <caption>
        <p>Dilatory responses in arteries from wild type and TLR4<sup>−/−</sup> mice, pre-contracted with EC<sub>80</sub> U46619. Dilation induced by (A) acetylcholine (Ach); <italic>n</italic> = 11 for wild type and <italic>n</italic> = 10 for TLR4<sup>−/−</sup> vessels. (B) SNP; <italic>n</italic> = 11 for wild type and <italic>n</italic> = 10 for TLR4<sup>−/−</sup> vessels. (C) MnCl<sub>2</sub>; <italic>n</italic> = 10 for wild type and <italic>n</italic> = 5 for TLR4<sup>−/−</sup> vessels. (D) Superoxide dismutase (SOD); <italic>n</italic> = 8 for wild type and <italic>n</italic> = 5 for TLR4<sup>−/−</sup> vessels. Data are represented as mean ± SEM. <sup>∗</sup><italic>p</italic> &lt; 0.05; ns, not significant by two-way ANOVA.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="f0010">
      <label>Fig. 2</label>
      <caption>
        <p>Contractile responses in arteries from wild type and TLR4<sup>−/−</sup> mice to (A) U46619; <italic>n</italic> = 27 for wild type and <italic>n</italic> = 20 for TLR4<sup>−/−</sup> vessels. Data are represented as mean ± SEM. <sup>∗</sup><italic>p</italic> &lt; 0.05 by two-way ANOVA; and (B) high [K<sup>+</sup>] <italic>n</italic> = 26 for wild type and <italic>n</italic> = 20 for TLR4<sup>−/−</sup> vessels. Data are represented as mean ± SEM. <sup>∗</sup><italic>p</italic> &lt; 0.05 by unpaired <italic>t</italic>-test.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="f0015">
      <label>Fig. 3</label>
      <caption>
        <p>Superoxide levels in the endothelial cell layer of (A) wild type and TLR4<sup>−/−</sup> arteries, with or without MnCl<sub>2</sub>. Left hand side images show arteries incubated with DHE which produces 2-hydroxyethidium when oxidised by <inline-formula><mml:math id="M1" altimg="si1.gif" overflow="scroll"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>O</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mtext/><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula>; middle images show blue fluorescence of the nuclear stain DAPI; right hand side images show DHE and DAPI combined. (B) Data are represented as mean pixel count ± SEM. ∗<italic>p</italic> &lt; 0.05 compared to wild type; <sup>#</sup><italic>p</italic> &lt; 0.05 for plus MnCl<sub>2</sub> versus TLR4<sup>−/−</sup> control by one-way ANOVA followed by Bonferroni’s Multiple Comparison Test, <italic>n</italic> = 6 mice. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="f0020">
      <label>Fig. 4</label>
      <caption>
        <p>Superoxide levels in the smooth muscle cell layer of (A) wild type and TLR4<sup>−/−</sup> arteries, with or without MnCl<sub>2</sub>. Left hand side images show arteries incubated with DHE which produces 2-hydroxyethidium when oxidised by <inline-formula><mml:math id="M2" altimg="si2.gif" overflow="scroll"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>O</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mtext/><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula>; middle images show blue fluorescence of the nuclear stain DAPI; right hand side images show DHE and DAPI combined. (B) Data are represented as mean pixel count ± SEM. ∗<italic>p</italic> &lt; 0.05 compared to wild type; <sup>#</sup><italic>p</italic> &lt; 0.05 for plus MnCl<sub>2</sub> versus TLR4<sup>−/−</sup> control by one-way ANOVA followed by Bonferroni’s Multiple Comparison Test, <italic>n</italic> = 6 mice. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
  </floats-group>
</article>